UBS Group’s Evotec EVO Stock Holding History
Bought
Maintained
Sold
Other funds holding EVO
DA
AA
OMC
FC
UBS Group's EVO Position: Q2 2026 in Review
UBS Group sold out of Evotec (EVO) in Q2 2026, closing a stake of 1,501 shares — an estimated $3.75K sold.
UBS Group first reported a position in EVO in Q4 2021 and held it in 17 quarters. The position peaked at $82.8K in Q2 2023. 34 funds tracked by Wall St. Rank hold EVO as of Q2 2026.
- UBS Group reported no remaining Evotec position as of Q2 2026 after selling out during the quarter.
- UBS Group sold 1,501 Evotec shares in Q2 2026, an estimated $3.75K.
- UBS Group first reported a position in Evotec in Q4 2021 and held it in 17 quarters.
- UBS Group's Evotec position peaked at $82.8K in Q2 2023.
- 34 funds tracked by Wall St. Rank held Evotec as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.